Supriya Lifescience Share Price Today (SUPRIYA)
TODAY IN ONE LINE
SUPRIYA fell 1.8% on light volume, lagging Nifty's -0.0% move, supported by recent strong earnings.
With a market cap of ₹6,688.52 Cr., it trades at a P/E of 31.98. Track live valuations, technical indicators, and peers comparison below. Check delivery conviction and recent filings to build your view.
How good is this company?
Overall performance across 5 key dimensions.
Supriya Lifescience flags & news
Key strengths, potential risks, and recent updates.
Green Flags
- ●Earnings GrowthEPS (TTM) grew by a solid 46.7% YoY
- ●Quarterly OutperformanceLatest quarter Sales up 50.2% and Profit up 47.3%
- ●High Capital EfficiencyROCE of 25.1% indicating pricing power
- ●Strong Return on EquityHealthy ROE of 19.1%
- ●Healthy Operating MarginsOPM is structurally strong at 35.5%
- ●High Promoter HoldingPromoters hold 68.3% skin-in-the-game
- ●Virtually Debt-FreeVery low Debt-to-Equity of 0.00x
- ●Zero Pledge RiskNo recent active promoter pledging found
Red Flags
- ●FII SellingFII holding decreased by 1.32% QoQ
Latest Supriya Lifescience News
What changed recently?
Recent events, corporate actions, and announcements.
Supriya Lifescience Limited valuation: P/E, P/B and sector benchmarks.
Twelve years of multiples investors have paid for Supriya Lifescience Limited, framed against the sector median so the premium or discount is obvious at a glance.
Supriya Lifescience Limited trades at a P/E of 31.98× and P/B of 5.58×.
Market-priced ratios use the latest available quote; accounting metrics use the latest reported filing. Compare values with matched peers and the company's own history.
Valuation
Profitability
Growth
Financial Health
Supriya Lifescience Limited technical analysis: indicators, pivots and CPR.
Live RSI, MACD and moving-average signals plus today's pivot and Central Pivot Range levels for Supriya Lifescience Limited — derived from the live tape, not yesterday's close.
Supriya Lifescience Limited last traded at ₹830.1 with an intraday range of ₹824.3–₹850.9 — live indicator, pivot and CPR signals below.
Pivot points
Standard pivot — most widely referenced.
Pivot levels · Classic
Live: ₹830.10| Level | Price (₹) | Distance | % Δ |
|---|---|---|---|
| R4 | 899.10 | +69.00 | +8.31% |
| R3 | 872.50 | +42.40 | +5.11% |
| R2 | 861.70 | +31.60 | +3.81% |
| R1 | 845.90 | +15.80 | +1.90% |
| PIVOT | 835.10 | 5.00 | 0.60% |
| CURRENT | 830.10 | — | — |
| S1 | 819.30 | -10.80 | -1.30% |
| S2 | 808.50 | -21.60 | -2.60% |
| S3 | 792.70 | -37.40 | -4.51% |
| S4 | 766.10 | -64.00 | -7.71% |
SUPRIYA is trading Below CPR, indicating Bearishness
CPR is Wider, suggesting unlikely for trending moves
Day's range: ₹835–₹850.9
Trading Below opening range, showing Bearishness
Supriya Lifescience Limited financials: P&L, balance sheet, cash flow, ratios.
Reported annual and quarterly results for Supriya Lifescience Limited — consolidated or standalone — with margins, YoY growth and key ratios inline.
Supriya Lifescience Limited reports its full P&L, balance sheet, cash flow and ratios on this page — current market capitalisation of ₹6,688.52 Cr. and reported EPS of ₹25.94.
Supriya Lifescience segment analysis : revenue and profit mix.
Disclosed business segments at Supriya Lifescience with their share of revenue and profit, switchable between consolidated and standalone reporting.
Supriya Lifescience discloses revenue and profit across multiple business segments — toggle between consolidated and standalone views to see the mix.
Segment-wise Financial Analysis
The Bull, Bear, and Flip case for Supriya Lifescience Limited.
Our AI distills the core fundamental drivers supporting Supriya Lifescience Limited, the risks that threaten it, and the quantitative conditions that could weaken the thesis.
Supriya Lifescience Limited's investment case rests on 10 positive markers and 10 flagged concerns drawn from the latest reported filings.
What you're getting.
Operating margin 32.09% far exceeds peer median ~16%, demonstrating exceptional pricing power
ROE 19.10% and ROCE 25.10% substantially exceed peer medians, signaling superior capital efficiency
Debt-to-equity 0.0000 with net cash ₹37.55 Cr indicates fortress-like balance sheet strength
TTM EPS grew 46.7% YoY; latest quarterly EPS grew 47.3% YoY despite revenue headwinds
Promoter holding 68.30% reflects stable insider confidence and long-term value commitment
Key Risks.
Latest quarterly sales declined 9.69% YoY, signaling near-term revenue deceleration and market headwinds
Latest quarterly profit fell 22.10% YoY despite TTM EPS growth, indicating margin compression pressure
Dividend yield 0.11% extremely low, unattractive for income-focused investors seeking regular returns
Beta 1.21 indicates stock volatility exceeds market average, elevating portfolio risk premium substantially
P/E ratio 35.66x TTM elevated relative to peer median 29.0x, pricing in significant growth expectations
Flip Conditions.
Valuation risk. a P/E above 42 would leave less room for earnings disappointment.
Reassess if quarterly profit growth turns negative for two consecutive quarters. The bull case relies on compounding earnings.
Return-quality risk. ROE below 14% would indicate weaker capital compounding.
Income thesis breaks if the dividend is cut or yield falls below 0.06%.
Supriya Lifescience Limited peer comparison — same-sector benchmarks.
Same-sector listed peers ranked on P/E, market cap, dividend yield and growth — Supriya Lifescience Limited is highlighted for quick read-across.
Quick Compare
Peer Comparison
| Company Name |
|---|
Supriya Lifescience Limited chart patterns: breakouts, tops and bottoms.
Auto-detected classical chart patterns for Supriya Lifescience Limited — Double Top/Bottom, Head & Shoulders, Triple Bottom and more — with break levels, targets and quality scores across Intraday, Daily and Weekly timeframes.
- 1Pick how to scan. Detection sets sensitivity — Daily (standard) → Weekly (big swings). History sets how far back to look.
- 2Read the summary. The tiles at the top give the current read: net bias, the strongest pattern, and the one nearest to triggering.
- 3Scan the list. Use the Actionable, Watchlist, and History tabs to browse patterns. Click a pattern card to focus it.
- 4Inspect on the chart. Focusing draws the pattern’s pivots plus its break (blue), target (amber) and invalidation lines.
- 5Filter to what matters. Use the status controls (Confirmed, Forming, Invalidated) to hide noise and find exactly what you are looking for.
Pattern history — every completed pattern and its outcome
Supriya Lifescience Limited delivery volume — last 20 sessions of conviction.
Daily traded volume and delivery percentage for Supriya Lifescience Limited over 20 sessions — the gap between intraday flipping and genuine accumulation.
Latest session delivery in Supriya Lifescience Limited stood at 44.3% of traded volume, against a 20-day average of 41.5%.
Supriya Lifescience announcements: results, concalls, ratings, M&A.
Filings Supriya Lifescience sent to the exchanges, sequenced as they hit the tape — concall transcripts, results, credit ratings and presentations.
Supriya Lifescience files concall transcripts, results, credit ratings and corporate-action notices on the NSE and BSE exchange portals — latest 114 documents below.
Copy of Newspaper Publication
Supriya Lifescience Limited has informed the Exchange about Copy of Newspaper Publication
Shareholders meeting
Supriya Lifescience Limited has informed the Exchange regarding Notice of Postal Ballot
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Supriya Lifescience Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
General Updates
Supriya Lifescience Limited has informed the Exchange about General Updates
Disclosure under SEBI Takeover Regulations
Satish Waman Wagh has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India…
Investor decks & rating reports.
Investor Presentation
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
Analysts/Institutional Investor Meet/Con. Call Updates
Investor Presentation
Investor Presentation
Supriya Lifescience dividend history, splits and bonus issues.
Every dividend, stock split and bonus issue Supriya Lifescience has declared, sequenced by announce and record date.
Supriya Lifescience corporate-action history below covers all declared dividends, stock splits and bonus issues recorded with NSE and BSE.
About Supriya Lifescience Limited: business, sector, key facts.
What Supriya Lifescience Limited does, where it operates, the people running it, and the numbers that describe the entity behind the ticker.
Supriya Lifescience Limited operates in the Pharmaceuticals industry under the Healthcare sector, listed as NSE: SUPRIYA, BSE: 543434.
Supriya Lifescience Limited is a global player in the pharmaceutical industry, specializing in the research, development, manufacturing, and sale of bulk drugs and pharmaceutical chemicals. Their primary focus is on the creation and distribution of Active Pharmaceutical Ingredients (APIs) used in a wide range of therapeutic areas.
The company's API portfolio encompasses various therapeutic segments including anti-histamines, anti-allergics, anti-asthmatics, decongestants, analgesics, antipyretics, anesthetics, anti-hypertensives, anti-malarials, vitamins, and products for treating gout. They also cater to the oncology, veterinary, and general pharmaceutical markets with a diverse range of products.
Beyond their core API business, Supriya Lifescience has expanded into the development and commercialization of specialized healthcare products. This includes GelHeal, a wound care solution, and Quickblue, a kit for the early detection of oral cancer. This diversification demonstrates their commitment to addressing a broader spectrum of healthcare needs.
Looking towards the future, Supriya Lifescience is actively engaged in the research and development of novel drugs across numerous therapeutic areas. Their pipeline includes potential treatments for depression, inflammation, various types of cancers, diabetes, obesity, migraine, and ataxia. They are also exploring opportunities in the development of contrast media, hormones, antibiotics, smoking cessation aids, and veterinary APIs. This aggressive R&D strategy signifies their commitment to innovation and expansion within the pharmaceutical landscape.
Established in 1987 and headquartered in Mumbai, India, Supriya Lifescience has a long history of serving the global pharmaceutical market. Their integrated approach, combining research, manufacturing, and sales, allows them to maintain a strong position in the competitive pharmaceutical industry and continue to explore new avenues for growth and development.
Related
Peers, sector trends, screeners and strategy playbooks contextual to this stock.
- Aarey Drugs & Pharmaceuticals (AAREYDRUGS) Share PricePeer
- Aarti Drugs (AARTIDRUGS) Share PricePeer
- Aarti Pharmalabs (AARTIPHARM) Share PricePeer
- Ajanta Pharma (AJANTPHARM) Share PricePeer
- Akums Drugs and Pharmaceuticals (AKUMS) Share PricePeer
- Top quality scorecard stocksScreener
- Top Gainers TodayScreener
- EMA Crossover ScreenerScreener
- Technical DashboardScreener
- Results CalendarScreener
- FII Buying ActivityScreener
- All Technical ScreenersScreener
- All Trading StrategiesStrategy
Questions investors ask about Supriya Lifescience Limited (SUPRIYA).
Quick answers grounded in this page's data — price action, fundamentals, ratios and ownership.
01What is the current share price of Supriya Lifescience Limited (SUPRIYA)?
The current share price of Supriya Lifescience Limited (SUPRIYA) is ₹830.1. Today, the stock has declined by ₹14.80 (1.75%), trading in a range of ₹824.3 to ₹850.9. The stock opened at ₹850 with a trading volume of 92,852 shares.
02Is Supriya Lifescience Limited stock a good investment for long-term?
Supriya Lifescience Limited can be considered for long-term investment based on several factors. The company has a market capitalization of ₹6,688.52 crores, P/E ratio of 31.98, ROE of 19.10%, and ROCE of 25.10%. The dividend yield stands at 0.11%. However, investment decisions should be based on your financial goals, risk appetite, and thorough research. It's recommended to consult with a SEBI-registered financial advisor before making investment decisions.
03What is the 52-week high and low price of Supriya Lifescience Limited stock?
The 52-week high price of Supriya Lifescience Limited (SUPRIYA) is ₹1,085, while the 52-week low is ₹545.5. Currently trading at ₹830.1, the stock is 52.8% away from its 52-week low and 23.5% below its 52-week high. These levels help investors understand the stock's price volatility and trading range over the past year.
04Should I buy Supriya Lifescience Limited stock at the current price?
Whether to buy Supriya Lifescience Limited stock at ₹830.1 depends on multiple factors. The stock is currently trading with a P/E ratio of 31.98 and P/B ratio of 5.58. Today's performance shows a loss of 1.75%. Consider analyzing the company's fundamentals, technical indicators, industry trends, and your investment horizon. Compare these metrics with industry peers and consult a financial advisor for personalized advice.
05What is the dividend yield of Supriya Lifescience Limited and when is the next dividend?
Supriya Lifescience Limited offers a dividend yield of 0.11%, which means for every ₹100 invested at the current price of ₹830.1, you can expect to receive approximately ₹0.11 annually as dividends. The face value of the stock is ₹2.00. For information about the next dividend announcement and ex-dividend date, please check the company's official announcements or visit the BSE/NSE websites.
06What are the key financial ratios and metrics of Supriya Lifescience Limited?
Supriya Lifescience Limited's key financial metrics include: P/E Ratio: 31.98, P/B Ratio: 5.58, ROE: 19.10%, ROCE: 25.10%, Dividend Yield: 0.11%, EPS: ₹25.94, Book Value: ₹148.77, and Debt-to-Equity: 0.00. The company's market cap stands at ₹6,688.52 crores. These metrics help evaluate the company's valuation, profitability, and financial health.
07How is Supriya Lifescience Limited stock performing today in the market?
Supriya Lifescience Limited stock opened at ₹850 and is currently trading at ₹830.1, showing a decline of ₹14.80 (1.75%). The intraday high is ₹850.9 and low is ₹824.3. The trading volume stands at 92,852 shares, indicating moderate market participation today.
08What is the P/E ratio of Supriya Lifescience Limited and what does it indicate?
Supriya Lifescience Limited has a Price-to-Earnings (P/E) ratio of 31.98, which means investors are willing to pay ₹31.98 for every ₹1 of earnings. With an EPS of ₹25.94, this P/E ratio suggests the stock may be trading at a premium, possibly due to high growth expectations. Compare this with industry peers and historical P/E ratios for better context.
The data, ratios and commentary about Supriya Lifescience Limited (SUPRIYA) on this page are published for educational and informational purposes only and are not investment, legal or tax advice. StockeZee is not a SEBI-registered investment adviser, research analyst or portfolio manager, and no content here should be construed as a recommendation to buy, hold or sell any security. Live and historical market data may be delayed, revised by the exchanges, or contain errors; figures sourced from third-party feeds and corporate disclosures may not always be current. Past performance is not indicative of future results, and equity investments carry the risk of capital loss. Before acting on anything you read here, please consult a SEBI-registered financial advisor and read all scheme-related documents carefully.